Sharon Bio Medicines receives FDA approval for Tajola API plant

Indian Pharmaceutical company Sharon bio medicine Ltd said it received the Establishment Inspection Report (EIR) from United States Food and Drug Amnistration for its manufacturing plant located at Tajola in Raigad Dist., Maharashtra.

The plant, which will make Active Pharmaceutical Ingredients is now approved by the USFDA and the generic drug user fee is pending.

“The supply of API to United States of America cannot be done unless generic drug user fee is paid,” it said.

Sharon Bio Medicine is a manufacturer of Intermediates, Active Pharmaceutical Ingredients and Finished Dosage Forms with an annual turnover of over $130 million, with 500 personnel & market presence in over 40 countries worldwide.



Tech Mahindra opens robotics, AI and digital services center in Dublin IT services provider Tech Mahindra opened a new facility in Dublin, Ireland to focus on emerging technologies such as Robotics and Automation, Business Analytics, Cloud Infrastructure and Digital Services.The new centre would employ around 150 engineers over the next three years and will help the company deliver technology services to clients in Ireland ...
Govt of India starts crack down on low-quality medicine makers The government of India has started conducting inspections at drug manufacturing units across the country to prevent the production of low-quality drugs and medicines in India.Typically, inspections are conducted by state authorities, while central agencies largely confine themselves to checking quality of final products put up on store shelves.H...
Alembic Pharmaceuticals receives FDA approval for hypertension tablets Alembic Pharmaceuticals Ltd said it received approval from the United States Food & Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.The Telmisartan and Amlodipine Tablets are equivalent to the Twynsta tablets of Boehringer Ingelheim Pharmaceuticals, Inc.An Abbreviated New Drug ...
Dr Reddy’s Labs launches osteoporosis drug in the US Dr Reddy's Laboratories Ltd said it launched raloxifene hydrochloride tablets --used to treat osteoporosis -- in the US market.Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, r...
Apollo Tyres to invest Rs 525 cr in Andhra Pradesh Apollo Tyres today signed an agreement with the Andhra Pradesh government to set up a manufacturing facility in the state.“As per the Memorandum of Understanding, the company will invest approx. Rs 525 cr for setting up this facility in Andhra Pradesh bordering the south-eastern coast of India,” said the company.The proposed manufacturing facility wi...
Mylan and Biocon submits breast cancer drug application to USFDA Mylan N.V. and Biocon Ltd. said they submitted Mylan’s biologics license application for a proposed biosimilar Trastuzumab, to the U.S. Food and Drug Administration.Biosimilar trastuzumab is a proposed biosimilar to branded Trastuzumab, which is indicated to treat certain HER2-positive breast and gastric cancers.HER2-positive breast cancer is a breas...
Rajesh Exports starts second phase of retail expansion with Bangalore Gold Jewellery exporter, Rajesh Exports Ltd said it launched its 81st retail showroom under it's brand name ´Shubh Jewellers´ at Bangalore.“With this launch the company has launched it's second phase of retail expansion. The company in the second phase of retail expansion has finalized plans to launch series of retail showrooms in the four southern state...
Reliance Jio interconnect dispute with Airtel, Idea to end this month The dispute over providing interconnection facility is set to end in the next two weeks, with Bharti Airtel, Idea Cellular and Vodafone giving in to the demands of new operator Reliance Jio and the regulator.The decision to comply comes in the wake of a recommendation for a fine of Rs 3,050 cr to be imposed on the three companies for what it said amounte...
Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets Marksans Pharma Ltd said the United States Food & Drug Administration has given its approval for its paricalcitol capsules -- a synthetic equivalent of Vitamin D.Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in the body. Paricalcitol Capsules are therapeutically equivalent to the reference l...
Thomas Cook tries the ‘mini’ approach to keep costs low in Tier 3 cities Thomas Cook, one of leading travel consultants, said it has launched an outlet in Rudrapur city in Uttarkhand under its new Mini format.The Rudrapur outlet has been designed optimising space and will be manned by a two member team, equipped with technology via mobile devices for seamless online connectivity to central systems thereby facilitating quick c...
Almebic Pharmaceuticals receives inspection report from USFDA Alembic Pharmaceuticals Ltd., said it received an Establishment Inspection Report from the United States Food and Drug Administration for the inspection carried out at their formulation facility at Panelav, Gujarat.The FDA has the authority to inspect any establishment in which food is manufactured, processed, packed, or held, in search of contamination....
Hexaware Technologies opens new operations center in Bucharest Hexaware Technologies Limited, a BPO and Digital services provider, said it has expanded its delivery presence in the European region by opening of its latest Global Delivery Centre in Bucharest, Romania.The Bucharest Global Delivery centre is situated in a prime location and in close proximity to several key clients within the European region, said the ...
Shilpa Medicare receives USFDA approval for generic bone marrow drug Shilpa Medicare Ltd said it received an approval from the United states Food & Drug Administration for Azacitidine injection.Azacitidine is used to treat myelodysplastic syndrome - a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells.The approval was received under ...
Lupin receives FDA approval for generic Namenda XR dementia capsules Pharma Major Lupin Ltd said it received final approval from United States Food and Drug Administration for selling Memantine Hydrochloride extended-release capsules, a generic version of Allergan’s Namenda XR capsules.Namenda XR extended-release capsules are approved by the USFDA for the treatment of moderate to severe dementia of the Alzheimer's disea...
Kilitch Drugs to set up plant in Ethiopia Kilitch Drugs (India) Ltd said its unit Kilitch Estro Biotech Plc acquired land for the installation of a pharma plant in Ethiopia.4317.5 sq. mtrs of land was allotted at Oromia special zone by the Bureau of Rural Land and Environmental Protection, Federal Democratic Republic of Ethiopia on lease for a period of 45 years.Kilitch undertakes contract m...